Glyxambi
Payments companies reported to CMS as associated with Glyxambi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Glyxambi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Glyxambi
These are the largest totals companies reported as associated with Glyxambi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Perry Herson | Williston Park, NY | $246.99 | |
| Ihor Magun | Rockville Ctr, NY | Internal Medicine | $239.33 |
| Sara Olson | Colorado Springs, CO | Medical | $198.46 |
| Michael Alaimo | Malverne, NY | Adult Medicine | $190.10 |
| Emmanuel St Louis | Uniondale, NY | Family Medicine | $187.00 |
| Linda Aquilino | Woodbury, NJ | Internal Medicine | $174.03 |
| Robert Marlow | Huntsville, AL | Family Medicine | $170.74 |
| Kolo Ediale | Monticello, NY | Endocrinology, Diabetes & Metabolism | $163.88 |
| Ross Summerford | Tuscaloosa, AL | Family Medicine | $162.25 |
| Samantha Isaac | Vinton, IA | Physician Assistant | $157.85 |
Prescribed Glyxambi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.